Elli Papaemmanuil

Elli Papaemmanuil is a distinguished expert in computational oncology and precision medicine, currently serving as Co-Founder and CEO of Isabl since December 2020, while also holding the position of Associate Professor at MSKCC since March 2015. With extensive experience in genomic applications and technology architecture, Elli participates in scientific advisory boards and consulting in the pharmaceutical sector and genomics companies. Academic roles include Junior Team Leader at the University of Cambridge and prior positions at the Wellcome Trust Sanger Institute and The Institute of Cancer Research. Educational credentials encompass a PhD in Human Population Genetics from the University of London, a Bachelor's degree in Human Molecular Genetics from the University of Glasgow, and ongoing postdoctoral studies at the University of Cambridge focused on cancer genomic biomarkers.